Atea Pharmaceuticals, Inc. (AVIR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -46.39M | -28.22M | -40.38M | -32.87M | -30.56M | -30.4M | -23.04M | -42.2M | -39.87M | -21.83M | -17.59M | -16.12M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -51.79% | 7.15% | -75.28% | 22.11% | 23.33% | -39.22% | -30.95% | -161.8% | -33.55% | -1.34% | 17.19% | 15.98% |
| Net Income | -45.44M | -44.87M | -42.05M | -37.16M | -34.27M | -33.54M | -31.15M | -40.52M | -63.17M | -39.16M | -33.14M | -28.18M |
| Depreciation & Amortization | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K |
| Stock-Based Compensation | 0 | 4.58M | 4.52M | 4.67M | 6.95M | 14.3M | 12.16M | 12.72M | 12.59M | 12.16M | 12.38M | 12.35M |
| Deferred Taxes | 0 | -6.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.51M | -37.46M | 0 |
| Other Non-Cash Items | 3.15M | -808K | -1.07M | -1.32M | -1.74M | -2.71M | -2.6M | -3.02M | -3.49M | 4.16M | 33.14M | -3.7M |
| Working Capital Changes | -4.2M | 19.12M | -1.87M | 841K | -1.61M | -8.54M | -1.56M | -11.48M | 14.1M | 9.41M | 7.38M | 3.3M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3.5M | 9.43M | -5.33M | 1.46M | 2.93M | -1.33M | 315K | -15.67M | 16.89M | 3.86M | -3.57M | 3.26M |
| Cash from Investing | 29.74M | 46.59M | 41.3M | 15.29M | 85.61M | -3.37M | -122.01M | 124.69M | 56.8M | 27.77M | -58.51M | 46.56M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 257K | 0 | -11.3M | -14.09M | -347K | 0 | 117K | 0 | 150K | 0 | 92K | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1M | 427K | -11.43M | -14.09M | 138K | 0 | 117K | 0 | 150K | 0 | 92K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -11.43M | -14.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -746K | -427K | 121K | 0 | -485K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -16.4M | 18.37M | -10.38M | -31.67M | 54.7M | -33.77M | -144.93M | 82.48M | 17.09M | 5.94M | -76.01M | 30.45M |
| Free Cash Flow | -46.39M | -28.22M | -40.38M | -32.87M | -30.56M | -30.4M | -23.04M | -42.2M | -39.87M | -21.83M | -17.59M | -16.12M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -51.79% | 7.15% | -75.28% | 22.11% | 23.33% | -39.22% | -30.95% | -161.8% | -33.55% | -1.34% | 17.27% | 23.47% |
| FCF per Share | -0.59 | -0.36 | -0.51 | -0.39 | -0.36 | -0.36 | -0.27 | -0.50 | -0.48 | -0.26 | -0.21 | -0.19 |
| FCF Conversion (FCF/Net Income) | 1.02x | 0.63x | 0.96x | 0.88x | 0.89x | 0.91x | 0.74x | 1.04x | 0.63x | 0.56x | 0.53x | 0.57x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |